Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lactobacillus plantarum {L. plantarum} - Lawsonibacter |
👶
Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1071284 Pub: 2022 Epub: 2023 Jan 9 Authors Cao F , Ding Q , Zhuge H , Lai S , Chang K , Le C , Yang G , Valencak TG , Li S , Ren D , Html Article Publication |
| Lactobacillus plantarum {L. plantarum} - Lawsonibacter |
👶
Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson's Disease: The Role of Gut Microbiota and MicroRNAs. International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 7 Pages: Pub: 2023 Apr 5 Epub: 2023 Apr 5 Authors Lee YZ , Cheng SH , Chang MY , Lin YF , Wu CC , Tsai YC , Html Article Publication |
| Lactobacillus plantarum {L. plantarum} - Lawsonibacter |
👶
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , Publication |
| Lactobacillus plantarum {L. plantarum} - Lawsonibacter |
👶
Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats. The British journal of nutrition (Br J Nutr ) Vol: 118 Issue 7 Pages: 481-492 Pub: 2017 Oct Epub: Authors Song JJ , Tian WJ , Kwok LY , Wang YL , Shang YN , Menghe B , Wang JG , Publication Publication |
| Lactobacillus plantarum {L. plantarum} - Lawsonibacter |
👶
Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 254 Issue Pt 1 Pages: 127624 Pub: 2023 Oct 31 Epub: 2023 Oct 31 Authors Wang Q , Jiang B , Wei M , He Y , Wang Y , Zhang Q , Wei H , Tao X , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
